Dr. Manuel R Modiano, MD
Claim this profileACRC/Arizona Clinical Research Center, Inc
Studies Breast Cancer
Studies Tumors
7 reported clinical trials
20 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage IV
Stage III
2Tumors
HER2 positive
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Manuel R Modiano, MD is currently running
Ramucirumab + Trifluridine/Tipiracil or Paclitaxel
for Gastric Cancer
This phase II trial studies the effect of the combination of ramucirumab and trifluridine/tipiracil or paclitaxel in treating patients with previously treated gastric or gastroesophageal junction cancer that has spread to other places in the body (advanced). Ramucirumab may damage tumor cells by targeting new blood vessel formation. Trifluridine/tipiracil is a chemotherapy pill and that may damage tumor cells by damaging their deoxyribonucleic acid (DNA). Paclitaxel may block cell growth by stopping cell division which may kill tumor cells. Giving ramucirumab and trifluridine/tipiracil will not be worse than ramucirumab and paclitaxel in treating gastric or gastroesophageal junction cancer.
Recruiting1 award Phase 21 criteria
ZN-A-1041 Combinations
for Breast Cancer
This trial is testing a new drug called ZN-A-1041 to see if it is safe and effective for patients with advanced cancers that have a specific marker called HER2. The drug aims to find and destroy these cancer cells, even if they have spread to the brain.
Recruiting1 award Phase 14 criteria
More about Manuel R Modiano, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Manuel R Modiano, MD has experience with
- ZN-A-1041
- T-DM1
- Herceptin
- Perjeta
- T-Dxd
- PHESGO
Breakdown of trials Manuel R Modiano, MD has run
Breast Cancer
Plasma Cell Neoplasms
Multiple Myeloma
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Manuel R Modiano, MD specialize in?
Manuel R Modiano, MD focuses on Breast Cancer and Tumors. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Manuel R Modiano, MD currently recruiting for clinical trials?
Yes, Manuel R Modiano, MD is currently recruiting for 4 clinical trials in Tucson Arizona. If you're interested in participating, you should apply.
Are there any treatments that Manuel R Modiano, MD has studied deeply?
Yes, Manuel R Modiano, MD has studied treatments such as ZN-A-1041, T-DM1, Herceptin.
What is the best way to schedule an appointment with Manuel R Modiano, MD?
Apply for one of the trials that Manuel R Modiano, MD is conducting.
What is the office address of Manuel R Modiano, MD?
The office of Manuel R Modiano, MD is located at: ACRC/Arizona Clinical Research Center, Inc, Tucson, Arizona 85715 United States. This is the address for their practice at the ACRC/Arizona Clinical Research Center, Inc.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.